Myeloproliferative neoplasms
JL Spivak - New England Journal of Medicine, 2017 - Mass Medical Soc
Myeloproliferative Neoplasms | New England Journal of Medicine Skip to main content The
New England Journal of Medicine homepage Advanced Search SEARCH SPECIALTIES …
New England Journal of Medicine homepage Advanced Search SEARCH SPECIALTIES …
Clinical insights into the origins of thrombosis in myeloproliferative neoplasms
AR Moliterno, YZ Ginzburg… - Blood, The Journal of the …, 2021 - ashpublications.org
Philadelphia chromosome–negative myeloproliferative neoplasms (MPNs), polycythemia
vera, essential thrombocythemia, and primary myelofibrosis, are hematopoietic stem cell …
vera, essential thrombocythemia, and primary myelofibrosis, are hematopoietic stem cell …
Impact of calreticulin mutations on clinical and hematological phenotype and outcome in essential thrombocythemia
G Rotunno, C Mannarelli, P Guglielmelli… - Blood, The Journal …, 2014 - ashpublications.org
Mutations in the calreticulin (CALR) gene were recently discovered in patients with essential
thrombocythemia (ET) lacking the JAK2 V617F and MPL W515 mutations, but no information …
thrombocythemia (ET) lacking the JAK2 V617F and MPL W515 mutations, but no information …
Bleeding, thrombosis, and anticoagulation in myeloproliferative neoplasms (MPN): analysis from the German SAL-MPN-registry
A Kaifie, M Kirschner, D Wolf, C Maintz, M Hänel… - Journal of hematology & …, 2016 - Springer
Abstract Background Patients with Ph-negative myeloproliferative neoplasms (MPN), such
as polycythemia vera (PV), essential thrombocythemia (ET), and primary myelofibrosis …
as polycythemia vera (PV), essential thrombocythemia (ET), and primary myelofibrosis …
How I treat polycythemia vera
JL Spivak - Blood, The Journal of the American Society of …, 2019 - ashpublications.org
Since its discovery, polycythemia vera (PV) has challenged clinicians responsible for its
diagnosis and management and scientists investigating its pathogenesis. As a clonal …
diagnosis and management and scientists investigating its pathogenesis. As a clonal …
Splanchnic vein thrombosis associated with myeloproliferative neoplasms
D Tremblay, A Winters, JD Beckman, L Naymagon… - Thrombosis …, 2022 - Elsevier
Splanchnic vein thrombosis (SVT) in the setting of myeloproliferative neoplasm (MPN) is a
unique clinical entity that requires close interdisciplinary coordination for proper diagnosis …
unique clinical entity that requires close interdisciplinary coordination for proper diagnosis …
Molecular profiling and risk classification of patients with myeloproliferative neoplasms and splanchnic vein thromboses
PE Debureaux, B Cassinat, J Soret-Dulphy… - Blood …, 2020 - ashpublications.org
Myeloproliferative neoplasms (MPNs) are the most frequent underlying causes of splanchnic
vein thromboses (SVTs). MPN patients with SVTs (MPN-SVT) often have a unique …
vein thromboses (SVTs). MPN patients with SVTs (MPN-SVT) often have a unique …
Sex determines the presentation and outcomes in MPN and is related to sex-specific differences in the mutational burden
The factors underlying the variable presentation and clinical course of myeloproliferative
neoplasms (MPNs) remain unclear. The aim of this study was to evaluate the independent …
neoplasms (MPNs) remain unclear. The aim of this study was to evaluate the independent …
[HTML][HTML] Associations between gender, disease features and symptom burden in patients with myeloproliferative neoplasms: an analysis by the MPN QOL International …
HL Geyer, H Kosiorek, AC Dueck, R Scherber… - …, 2017 - ncbi.nlm.nih.gov
The myeloproliferative neoplasms, including polycythemia vera, essential thrombocythemia
and myelofibrosis, are distinguished by their debilitating symptom profiles, life-threatening …
and myelofibrosis, are distinguished by their debilitating symptom profiles, life-threatening …
Age-related differences in disease characteristics and clinical outcomes in polycythemia vera
The natural history and prognosis for young patients with polycythemia vera (PV) in the post-
JAK2 V617F era are not well defined. Therefore, we retrospectively analyzed disease …
JAK2 V617F era are not well defined. Therefore, we retrospectively analyzed disease …